In the words of the FDA, photon-counting CT (PCCT) is the “First Major Imaging Device Advancement for Computed Tomography in Nearly a Decade." This new detector technology measures X-ray photons differently than previous conventional scintillator-based detectors and offers tremendous potential for a quantum leap in CT imaging. Siemens Healthineers has introduced this technology to the market with the NAEOTOM Alpha.
Join this session and hear from a top subject matter expert at Siemens Healthineers how this new system helps users impact treatment outcomes with answers that are truly meaningful, precise and reproducible. Learn how PCCT can help you benefit from confident therapeutic decision-making and potentially scan patients who may have been previously excluded – thanks to a never-before-seen range of clinical options, high-resolution images at minimal dose and breakthrough consistency.
Upon completion of the seminar, participants will be able to:
Recognize the basic conventional CT detectors
Distinguish the basics of photon-counting CT detectors
Explain why and how the differences matter both technically and clinically
Identify a number of clinical examples where photon-counting CT improved understanding or operation
Cassling strengthens community healthcare through customer-centric imaging and therapeutic technology, services and solutions. From critical access hospitals and diagnostic imaging centers to large health systems and IDNs, Cassling is committed to helping healthcare organizations improve access and outcomes, create efficiencies and lower costs.